Supplementary Table S2 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Mutect2 called and validated variants for each subject and each tumor region from whole exome sequencing data